Sequential Adjuvant Epirubicin-Based and Docetaxel Chemotherapy for Node-Positive Breast Cancer Patients: The FNCLCC PACS 01 Trial - Concepedia

Concepedia

Publication | Open Access

Sequential Adjuvant Epirubicin-Based and Docetaxel Chemotherapy for Node-Positive Breast Cancer Patients: The FNCLCC PACS 01 Trial

DOI Full Paper Access

570

Citations

33

References

2006

Year

Henri Roché, P. Fumoleau, M. Spielmann, Jean-Luc Canon, T. Delozier, Daniel Serin, Michel Symann, Pierre Kerbrat, P Soulié, Françoise Eichler,

Journal of Clinical Oncology

Abstract

Sequential adjuvant chemotherapy with FEC followed by docetaxel significantly improves disease-free and overall survival in node-positive breast cancer patients and has a favorable safety profile.

References

	Year	Citations

Page 1